4503.T

Astellas Pharma Inc. · Healthcare · Drug Manufacturers - General

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$26.47B

PE Ratio

14.55

EV to Ebitda

—

Earnings Yield

7.00%

Revenue (TTM)

$13.50B

Net Income (TTM)

$1.84B

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

21.00%

Profit Margin

14.00%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

—

All fundamentals

Core6 fields›

Market Cap$26.47B

Revenue TTM$13.50B

Shares Outstanding1.79B

Float1708749184

Insider Ownership0.00%

Institutional Ownership59.00%

Growth Estimates8 fields›

Revenue Growth (Quarterly YoY)21.00%

Rev Growth Est 1Y Forward-0.08

EPS Growth (Quarterly YoY)-3.00%

EPS Growth Est Quarterly21.44

LT EPS Growth Estimates-7.00%

EBITDA Growth (Quarterly YoY)-3.00%

CFO Growth (Quarterly YoY)99.00%

FCF Growth (Quarterly YoY)102.00%

Operations21 fields›

Revenue TTM$13.50B

Gross Margin TTM81.00%

Gross Margin (Quarterly)76.00%

Operating Margin TTM17.00%

Operating Margin (Quarterly)14.00%

Operating Expenses TTM$88.8M

Profit Margin TTM14.00%

Profit Margin (Quarterly)8.00%

Net Income TTM$1.84B

EPS TTM162.21

EPS (Quarterly)24.35

EBITDA Margin TTM27.00%

EBITDA Margin (Quarterly)24.00%

EBITDA TTM$3.63B

CFO % of Revenue TTM26.00%

CFO % of Revenue (Quarterly)38.00%

CFO TTM$3.57B

Capex % of Revenue TTM3.00%

Capital Expenditures$364.3M

FCF % of Revenue (Quarterly)24.00%

FCF TTM$3.21B

Efficiency1 fields›

ROA7.00%

Valuation11 fields›

P/E (TTM)14.55

P/E Forward12.35

PEG0.37

P/CFO7.49

P/FCF8.34

EV/Revenues (TTM)1.98

Price To Book2.32

Price to Tangible Book10.8

Earnings Yield7.00%

FCF Yield12.00%

Payout Ratio48.00%

Liquidity8 fields›

Cash Per Share156.7

Current Ratio1.17

Goodwill & Intangibles$1438107.00T

Total Assets$22.51B

Total Liabilities$45.86B

Shareholders Equity$11.55B

Interest Expense$88.8M

Goodwill % of Assets40316514.00%

Yields3 fields›

Payout Ratio48.00%

Earnings Yield7.00%

Buyback Yield1.00%